Clinical study on the remission stage of chronic obstructive pulmonary disease treated by regulate and reinforce lung and kidney
Objective To explore the clinical effect of the remission stage of chronic obstructive pulmonary disease(COPD)treated by regulate and reinforce lung and kidney.Methods A total of 94 patients with COPD in remission stage admitted to Jiangxi Chest Hospital from May 2021 to May 2023 were selected as the research objects.According to the random number table method,they were divided into the control group(47 cases)and the observation group(47 cases).The control group was treated with conventional western medicine,and the observation group was treated with regulate and reinforce lung and kid-ney(Liuwei Dihuang Decoction modified and subtract and pressing specific acupuncture points treatment).Both groups were treated continuously for 12 weeks.The clinical efficacy,lung function,blood gas index,dyspnea degree,quality of life,tradi-tional Chinese medicine syndrome score and adverse reactions were compared between the two groups.Results The total ef-fective rate of the observation group was higher than that of the control group,and the difference was statistically significant(P＜0.05).There were no statistically significant differences in forced expiratory volume in first second(FEV1),forced vital capacity(FVC),FEV1/FVC,partial pressure of carbon dioxide(PaCO2),partial pressure of oxygen(PaO2),traditional Chinese medicine syndrome score,modified version of British Medical Reseach Council respiratory questionnaire(mMRC)and COPD assessment test(CAT)between the two groups before treatment(P＞0.05).After treatment,FEV1,FVC,FEV1/FVC,and PaO2 in the two groups were higher than those before treatment,while PaCO2,traditional Chinese medicine syndrome scores,mMRC,and CAT scores were lower than those before treatment,with statistical significances(P＜0.05).After treat-ment,the FEV1,FVC,FEV1/FVC,and PaO2 in the observation group were higher than those in the control group,while Pa-CO2,traditional Chinese medicine syndrome scores,mMRC,and CAT scores were lower than those in the control group,with statistical significances(P＜0.05).There was no statistically significant difference in the total incidence of adverse reactions between the two groups(P＞0.05).Conclusion The application of regulate and reinforce lung and kidney in the treatment of COPD patients in the remission stage has high value,which can improve ventilation and lung function,alleviate breathing difficulties,improve quality of life,be safe and reliable,and have significant effects.
Chronic obstructive pulmonary diseaseRegulate and reinforce lung and kidneyPressing needleLiuwei DiHuang Decoction
万方数据
维普
